Passive immunoneutralization of human immunodeficiency virus in patients with advanced AIDS. (Q45839741)

16 December 2017

title

Passive immunoneutralization of human immunodeficiency virus in patients with advanced AIDS. (English)

1 reference

16 December 2017

0 references

0 references

G G Jackson

1

1 reference

16 December 2017

J T Perkins

2

1 reference

16 December 2017

M Rubenis

3

1 reference

16 December 2017

D A Paul

4

1 reference

16 December 2017

M Knigge

5

1 reference

16 December 2017

J C Despotes

6

1 reference

16 December 2017

P Spencer

7

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 September 1988

1 reference

16 December 2017

published in

The Lancet

1 reference

16 December 2017

volume

2

1 reference

16 December 2017

issue

8612

1 reference

16 December 2017

page(s)

647-652

1 reference

16 December 2017

Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency, and disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Correlation of serum HIV antigen and antibody with clinical status in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Correlation of enzyme-linked immunosorbent assays for serum human immunodeficiency virus antigen and antibodies to recombinant viral proteins with subsequent clinical outcomes in a cohort of asymptomatic homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

Antibody-dependent enhancement of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

T-cytotoxic/suppressor cell phenotypes in a group of asymptomatic homosexual men with and without exposure to HTLV-III/LAV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990468-0

7 January 2021

10.1016/S0140-6736(88)90468-0

Identifiers

DOI

1 reference

16 December 2017

1 reference

16 December 2017